NanoVibronix Inc.'s subsidiary, ENvue Medical, has announced the launch of its innovative ENvue Drive™ platform, an intelligent robotic system designed to enhance bedside feeding tube and vascular line navigation. This next-generation development aims to automate electromagnetic navigation for enteral and vascular access procedures, addressing the need to increase procedural volume with fewer hands at the bedside. The ENvue Drive™ system integrates with FDA-cleared electromagnetic guidance technology, offering automated alignment and positional stability while allowing clinicians to maintain full control. This strategic initiative builds on ENvue Medical's momentum, including a dual-system acquisition agreement with a major Northeastern U.S. hospital and the issuance of a new U.S. patent for its electromagnetic guidance system for pediatric applications. The company continues to expand geographically across the Southeast, Midwest, and Northeastern U.S., with growing market penetration.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。